BACKGROUND: With the help of a measurement feedback system, the treatment strategy for individual @entity1 with @entity309 ( @entity309 ) can be adjusted to achieve optimal control of disease activity. OBJECTIVE: To study whether a measurement feedback system is effective in reducing disease activity in @entity1 with @entity309 . METHODS: Forty eight rheumatologists and 264 @entity1 participated in a controlled clinical trial. A three month control period was followed by a 12 month period, where feedback on disease activity, disability, and damage was provided to the rheumatologist. The primary outcome measure was the @entity309 activity index (RADAI). RESULTS: The feedback system was used for 142/228 (62%) @entity1 . Disease modifying antirheumatic drug changes occurred in 69/169 (41%) @entity1 . In @entity1 with high disease activity and feedback use (n=70), the RADAI decreased in the feedback period by -0.27 points per 30 days (p<0.05), as compared with the control period. @entity1 for whom the feedback system was used had a better outcome than non-users. CONCLUSION: Much more training on the use of a feedback system and outcome measures, as well as the inclusion of explicit treatment guidelines will be necessary to increase the clinical use of measurement feedback and, possibly, to reduce disease activity for a larger number of @entity1 with @entity309 .

Effectiveness of a measurement feedback system on outcome in XXXX : a controlled clinical trial.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity309 :: ('MESH:D001172', 'Disease') :: ['rheumatoid arthritis', 'RA', 'rheumatoid arthritis disease']
@entity309 :: (MESH:D001172,Disease) :: ['rheumatoid arthritis']
